Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection

被引：0
|
作者：
Paul Feuerstadt
Simon J. Hong
Lawrence J. Brandt
机构：
[1] Gastroenterology Center of Connecticut,Division of Digestive Disease
[2] Yale University School of Medicine,Division of Gastroenterology
[3] Albert Einstein College of Medicine/Montefiore Medical Center,undefined
来源：
Digestive Diseases and Sciences | 2020年 / 65卷
关键词：
Cirrhosis; Rifaximin; Infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：632 / 638
页数：6
相关论文
共 50 条
  • [1] Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection
    Feuerstadt, Paul
    Hong, Simon J.
    Brandt, Lawrence J.
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (02) : 632 - 638
  • [2] Breakthrough Clostridium difficile Infection in Cirrhotic Patients Receiving Rifaximin
    Reigadas, Elena
    Alcala, Luis
    Gomez, Javier
    Marin, Mercedes
    Martin, Adoracion
    Onori, Raffaella
    Munoz, Patricia
    Bouza, Emilio
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (07) : 1086 - 1091
  • [3] MELD is the only predictor of short-term mortality in cirrhotic patients with C. difficile infection
    Hong, Simon J.
    Feuerstadt, Paul
    Brandt, Lawrence J.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (02) : 275 - 280
  • [4] Improvement of sleep architecture parameters in cirrhotic patients with recurrent hepatic encephalopathy with the use of rifaximin
    Bruyneel, Marie
    Serste, Thomas
    Libert, Walter
    van den Broecke, Sandra
    Ameye, Lieveke
    Dachy, Bernard
    Mulkay, Jean-Pierre
    Moreno, Christophe
    Gustot, Thierry
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (03) : 302 - 308
  • [5] Clostridium difficile Infection in Hospitalized Cirrhotic Patients with Hepatic Encephalopathy
    Stoica, Oana Cristina
    Stanciu, Carol
    Cojocariu, Camelia
    Miftode, Egidia
    Boiculese, Lucian
    Trifan, Anca
    Girleanu, Irina
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2015, 24 (04) : 423 - 428
  • [6] Outcomes associated with Clostridium difficile infection in patients with chronic liver disease
    Dotson, Kierra M.
    Aitken, Samuel L.
    Sofjan, Amelia K.
    Shah, Dhara N.
    Aparasu, Rajender R.
    Garey, Kevin W.
    EPIDEMIOLOGY AND INFECTION, 2018, 146 (09) : 1101 - 1105
  • [7] C. difficile Infection in Children: What’s New?
    Jennifer Hellmann
    Daniel Mallon
    Current Treatment Options in Pediatrics, 2018, 4 (2) : 255 - 269
  • [8] Prevention and treatment of C. difficile in cancer patients
    Puerta-Alcalde, Pedro
    Garcia-Vidal, Carolina
    Soriano, Alex
    CURRENT OPINION IN INFECTIOUS DISEASES, 2023, 36 (06) : 473 - 480
  • [9] Lack of Clostridium difficile Infection in Patients Treated With Rifaximin for Hepatic Encephalopathy A Retrospective Analysis
    Neff, Guy W.
    Jones, Michael
    Jonas, Mark
    Ravinuthala, Ravi
    Novick, David
    Kaiser, Tiffany E.
    Kemmer, Nyingi
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (02) : 188 - 192
  • [10] The role of fungi in C. difficile infection: An underappreciated transkingdom interaction
    Stewart, David
    Romo, Jesus A.
    Lamendella, Regina
    Kumamoto, Carol A.
    FUNGAL GENETICS AND BIOLOGY, 2019, 129 : 1 - 6
12345